Source: Annual Congress 2008 - PG19 - Ventilatory management and cough enhancement in patients with neuromuscular disease



Rating:

Share or cite this content

Citations should be made in the following way:
A. Simonds (London, United Kingdom). Ventilatory impairment in neuromuscular dysfunction: What to measure? When to treat?. Annual Congress 2008 - PG19 - Ventilatory management and cough enhancement in patients with neuromuscular disease

Member's Comments

No comment yet.

Related content which might interest you: Cough dysfunction: What to measure? When to treat? Source: Annual Congress 2008 - PG19 - Ventilatory management and cough enhancement in patients with neuromuscular disease Year: 2008 Hypoventilation during sleep in neuromuscular and skeletal diseases: how to diagnose, when and how to treat, how to follow up? Source: 5th Sleep and Breathing Conference Year: 2019 Rapid decline in neuromuscular disease: when should home mechanical ventilation be considered? Source: Annual Congress 2007 - Rapid decline in lung function and its consequences Year: 2007 Airway clearance for children with neuromuscular disease: when and how? Source: International Congress 2014 – PG06 Respiratory evaluation and management of neuromuscular diseases in children Year: 2014 Pro/Con Debate "Muscle dysfunction, systemic inflammation and rehabilitation: is physical activity beneficial in COPD?" - CON Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD Year: 2011 Pro/Con Debate "Muscle dysfunction, systemic inflammation and rehabilitation: is physical activity beneficial in COPD?" - PRO Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD Year: 2011 Is a degree of asthma therapy related to pulmonary function impairment? Source: Eur Respir J 2001; 18: Suppl. 33, 41s Year: 2001 Lung function disturbances in 1084 sarcoidosis patients: which type of ventilatory impairment is the most common? Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis Year: 2006 Muscular disfunction in COPD: Systemic effect or deconditioning? Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities Year: 2013 Ventilatory support for patients with neuromuscular disorders Source: International Congress 2019 – Respiratory muscle dysfunction in an intensive care unit Year: 2019 Structure and function of the respiratory muscles in patients with COPD: impairment or adaptation? Source: Eur Respir J 2003; 22: 41S-51S Year: 2003 Noninvasive ventilation in children with neuromuscular disease: when, how and for how long? Source: Annual Congress 2012 - Respiratory support in children and young adults with neuromuscular disease Year: 2012 Impaired muscle mitochondrial density and/or function: a COPD-specific mitochondropathy or simply deconditioning? Source: Eur Respir J 2012; 40: 1070-1071 Year: 2012 Mild persistent asthma: to treat or not to treat regularly? Source: ERS Live 2007 Year: 2007 Resting cardiovascular function and ventilatory drive: correlation with exercise hyperventilation and sleep disturbances in chronic heart failure patients Source: Annual Congress 2008 - Assessment of the respiratory system Year: 2008